MCL coexpression mm9:820

Phase1 CAGE Peaks

	Short description
Mm9::chr14:55086951..55086964,+	p@chr14:55086951..55086964 +
Mm9::chr19:6051392..6051406,+	p@chr19:6051392..6051406 +
Mm9::chr1:172771902..172771921,-	p@chr1:172771902..172771921 -
Mm9::chr1:95321940..95321965,-	p@chr1:95321940..95321965 -
Mm9::chr2:26296488..26296491,-	p@chr2:26296488..26296491 -
Mm9::chr4:115550901..115550936,+	p@chr4:115550901..115550936 +
Mm9::chr5:138038533..138038546,-	p@chr5:138038533..138038546 -
Mm9::chr6:83005487..83005519,+	p@chr6:83005487..83005519 +
Mm9::chr8:124121679..124121694,+	p@chr8:124121679..124121694 +

Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

---

GO ID	GO name	FDR corrected p-value
GO:0006869	lipid transport	0.00247432988600952
GO:0005041	low-density lipoprotein receptor activity	0.0167579387420351
GO:0030169	low-density lipoprotein binding	0.0167579387420351
GO:0030228	lipoprotein receptor activity	0.0167579387420351
GO:0008034	lipoprotein binding	0.0217793521110023
GO:0006629	lipid metabolic process	0.02533347301713
GO:0005905	coated pit	0.037060117484394
GO:0005319	lipid transporter activity	0.0480788217914411

Relative expression of the co-expression cluster over median <br>Analyst:

---

Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>

---

Cell Type

Ontology term	p-value	n

Uber Anatomy

Ontology term	p-value	n

Disease

Ontology term	p-value	n

TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

---

Novel motifs

JASPAR motifs

Motifs	-log10(p-value)
{{{tfbs_overrepresentation_jaspar}}}